Sign up
Log in
Synopsys, Rocket Companies, On Holding And A Health Care Stock On CNBC's 'Final Trades'
Share
Listen to the news

On CNBC's “Halftime Report Final Trades,” Hightower Advisors’ Stephanie Link picked Synopsys, Inc. (NASDAQ:SNPS) as her final trade.

Sunnyvale, California-based Synopsys is scheduled to report results for the first quarter on Wednesday, Feb. 25, after the closing bell.

Analysts expect the company to report quarterly earnings at $3.56 per share on revenue of $2.39 billion.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he likes Rocket Companies, Inc. (NYSE:RKT) right here.

Barclays analyst Terry Ma, on Jan. 6, maintained Rocket Companies with an Equal-Weight rating and raised the price target from $19 to $22.

Rob Sechan, CEO of NewEdge Wealth, named Gilead Sciences, Inc. (NASDAQ:GILD) as his final trade.

Lending support to his choice, Citigroup analyst Geoff Meacham, on Jan. 27, maintained a Buy rating on Gilead and raised the price target from $140 to $156, while Truist Securities analyst Gregory Renza maintained a Buy rating and boosted the price target from $140 to $145.

Don't forget to check out our premarket coverage here

Jim Lebenthal, partner at Cerity Partners, said On Holding AG (NYSE:ONON) will report earnings in a couple of earnings, and is expected to show great holiday sales.

BTIG analyst Janine Stichter, on Jan. 29, reiterated On Holding with a Buy rating and maintained a $70 price target.

Price Action:

  • Rocket Companies shares dipped 13.7% to close at $17.93 on Friday.
  • Gilead Sciences shares gained 1.7% to settle at $141.95 during the session.
  • On Holding shares rose 0.8% to close at $45.25 on Friday.
  • Synopsys shares fell 3.1% to settle at $465.11.

Image: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.